Sangamo Therapeutics, Inc.
US ˙ NasdaqCM ˙ US8006771062

Introduction

This page provides a comprehensive analysis of the known insider trading history of Herberts Curt A. III. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Herberts Curt A. III has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:SNTI / Senti Biosciences, Inc. Chief Operating Officer 454,208
US:SGMO / Sangamo Therapeutics, Inc. Sr.VP & Chief Business Officer 3,750
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Herberts Curt A. III. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases SGMO / Sangamo Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SGMO / Sangamo Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insider Sales SGMO / Sangamo Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SGMO / Sangamo Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insider Purchases SNTI / Senti Biosciences, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SGMO / Sangamo Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SNTI / Senti Biosciences, Inc. Insider Trades
Insider Sales SNTI / Senti Biosciences, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SGMO / Sangamo Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SNTI / Senti Biosciences, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Herberts Curt A. III as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-06-15 3 SNTI Senti Biosciences, Inc.\
Common Stock
454,208
2018-04-17 2018-04-13 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -8,163 3,750 -68.52
2018-04-17 2018-04-13 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -8,163 14,625 -35.82 20.00 -163,260 292,500
2018-04-17 2018-04-13 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 8,163 22,788 55.82 14.07 114,853 320,627
2018-04-04 2018-04-02 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -1,563 53,125 -2.86
2018-04-04 2018-04-02 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -715 16,605 -4.13
2018-04-04 2018-04-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -2,278 14,625 -13.48 18.30 -41,684 267,614
2018-04-04 2018-04-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 1,563 16,903 10.19 3.50 5,470 59,160
2018-04-04 2018-04-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 715 15,340 4.89 9.41 6,728 144,349
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -5,312 54,688 -8.85
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -1,430 17,320 -7.63
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -8,087 11,913 -40.44
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -171 0 -100.00
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -15,000 14,625 -50.63 23.06 -345,861 337,214
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 5,312 29,625 21.85 3.50 18,592 103,688
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 8,087 24,313 49.84 14.07 113,784 342,084
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 1,430 16,226 9.66 9.41 13,456 152,687
2018-03-05 2018-03-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 171 14,796 1.17 12.12 2,073 179,328
2018-02-05 2018-02-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -15,000 60,000 -20.00
2018-02-05 2018-02-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -15,000 14,625 -50.63 20.59 -308,854 301,133
2018-02-05 2018-02-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 15,000 29,625 102.56 3.50 52,500 103,688
2018-01-31 2018-01-24 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 50,250 50,250
2018-01-31 2018-01-24 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
A - Award 8,375 14,625 134.00
2018-01-04 2018-01-03 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -8,026 171 -97.91
2018-01-04 2018-01-03 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -8,026 6,250 -56.22 18.05 -144,869 112,812
2018-01-04 2018-01-03 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 8,026 14,276 128.42 12.12 97,275 173,025
2018-01-04 2018-01-02 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -209 3,959 -5.01
2018-01-04 2018-01-02 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -782 18,750 -4.00
2018-01-04 2018-01-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -6,974 6,250 -52.74 16.35 -114,025 102,188
2018-01-04 2018-01-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 209 13,224 1.61 8.87 1,854 117,297
2018-01-04 2018-01-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 782 13,015 6.39 9.41 7,359 122,471
2017-12-12 2017-12-11 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
F - Taxes -1,252 12,233 -9.28 15.85 -19,844 193,893
2017-12-12 2017-12-08 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
F - Taxes -2,348 13,485 -14.83 16.90 -39,681 227,896
2017-12-06 2017-12-04 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -11,803 8,197 -59.02
2017-12-06 2017-12-04 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -11,803 15,833 -42.71 18.00 -212,454 284,994
2017-12-06 2017-12-04 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 11,803 27,636 74.55 12.12 143,052 334,948
2017-12-04 2017-12-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -416 4,168 -9.08
2017-12-04 2017-12-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -781 19,532 -3.84
2017-12-04 2017-12-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -3,197 15,833 -16.80 16.70 -53,390 264,411
2017-12-04 2017-12-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 416 19,030 2.23 8.87 3,690 168,796
2017-12-04 2017-12-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 781 18,614 4.38 9.41 7,349 175,158
2017-12-04 2017-11-30 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -13,433 20,313 -39.81
2017-12-04 2017-11-30 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -13,433 17,833 -42.96 16.00 -214,928 285,328
2017-12-04 2017-11-30 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 13,433 31,266 75.33 9.41 126,405 294,213
2017-12-04 2017-12-01 4/A SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -416 4,168 -9.08
2017-12-04 2017-12-01 4/A SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -781 19,532 -3.84
2017-12-04 2017-12-01 4/A SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -3,197 15,833 -16.80 16.70 -53,390 264,411
2017-12-04 2017-12-01 4/A SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 416 19,030 2.23 8.87 3,690 168,796
2017-12-04 2017-12-01 4/A SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 781 18,614 4.38 9.41 7,349 175,158
2017-12-04 2017-11-30 4/A SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -13,433 20,313 -39.81
2017-12-04 2017-11-30 4/A SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -13,433 17,833 -42.96 16.00 -214,928 285,328
2017-12-04 2017-11-30 4/A SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 13,433 31,266 75.33 9.41 126,405 294,213
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -3,754 33,746 -10.01
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -5,416 4,584 -54.16
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -5,830 0 -100.00
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -3,754 15,833 -19.17 16.00 -60,064 253,328
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 3,754 19,587 23.71 9.41 35,325 184,314
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -5,416 15,833 -25.49 15.00 -81,240 237,495
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 5,416 21,249 34.21 8.87 48,040 188,479
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -5,830 15,833 -26.91 15.00 -87,450 237,495
2017-10-04 2017-10-02 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 5,830 21,663 36.82 5.41 31,540 117,197
2017-09-01 2017-09-01 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -10,316 5,830 -63.89
2017-09-01 2017-09-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -10,316 15,833 -39.45 15.00 -154,740 237,495
2017-09-01 2017-09-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 10,316 26,149 65.16 5.41 55,810 141,466
2017-09-01 2017-09-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -4,684 15,833 -22.83 15.00 -70,260 237,495
2017-08-15 2017-08-14 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -5,000 0 -100.00
2017-08-15 2017-08-14 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -5,000 20,517 -19.59 11.00 -55,000 225,687
2017-08-15 2017-08-14 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 5,000 25,517 24.37 5.12 25,600 130,647
2017-08-15 2017-08-11 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -3,000 0 -100.00
2017-08-15 2017-08-11 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -3,474 0 -100.00
2017-08-15 2017-08-11 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -6,474 20,517 -23.99 10.00 -64,740 205,170
2017-08-15 2017-08-11 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 3,000 26,991 12.50 2.55 7,650 68,827
2017-08-15 2017-08-11 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 3,474 23,991 16.93 3.99 13,861 95,724
2017-07-14 2017-07-14 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -172 3,474 -4.72
2017-07-14 2017-07-14 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -14,828 20,517 -41.95 10.00 -148,280 205,170
2017-07-14 2017-07-14 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -172 35,345 -0.48 10.00 -1,720 353,450
2017-07-14 2017-07-14 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 172 35,517 0.49 3.99 686 141,713
2017-06-02 2017-06-01 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -2,000 35,345 -5.36 6.80 -13,600 240,346
2017-05-15 2017-05-12 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -2,000 37,345 -5.08 8.50 -17,000 317,432
2017-05-15 2017-05-11 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale X -639 39,345 -1.60 6.50 -4,154 255,742
2017-01-30 2017-01-26 4 SGMO SANGAMO THERAPEUTICS, INC
Employee Stock Option (Right to Buy)
A - Award 75,000 75,000
2016-12-14 2016-12-12 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
F - Taxes -4,852 33,300 -12.72 3.05 -14,799 101,565
2016-12-02 3 SGMO SANGAMO BIOSCIENCES INC
Common Stock
76,304
2016-12-02 3 SGMO SANGAMO BIOSCIENCES INC
Common Stock
76,304
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)